Chicago Reports Spike in Meningococcal Disease Cases, Two Deaths Confirmed

Chicago, IL – The Chicago Department of Public Health (CDPH) has reported a concerning increase in meningococcal disease cases among adults. Since January 15, seven confirmed infections have been identified, resulting in two associated deaths. This incidence rate is notably higher than the city's typical annual average of 10 to 15 cases of Neisseria meningitidis infections per year. The CDPH is actively investigating these cases.

Current Outbreak Details

Since mid-January, seven cases of Neisseria meningitidis have been reported in adults across Chicago, leading to two fatalities. This marks a significant concentration compared to the city's usual annual caseload. Notably, two of the recently reported cases occurred in individuals residing in the same homeless shelter. Despite this, the CDPH has yet to identify any direct links among the broader community cases.

Understanding Meningococcal Disease

Meningococcal disease, caused by the bacterium Neisseria meningitidis, is a serious and rapidly progressing illness. It can lead to severe infections, primarily:

• Meningitis: Infection of the lining of the brain and spinal cord.
• Sepsis: Life-threatening bloodstream infections.

Infections can worsen rapidly, potentially becoming life-threatening within hours if left untreated.

Even with antibiotic treatment, the fatality rate for infected individuals ranges between 10% and 20%. Survivors may face long-term complications such as hearing loss and damage to extremities, which in some cases may necessitate amputation.

Initial symptoms can often mimic the flu, but prompt medical attention is crucial if they appear. Key symptoms include:

• Fever
• Headache
• Stiff neck
• Nausea and vomiting
• Increased sensitivity to light
• Confusion
• Chills
• Fatigue
• Cold extremities
• Severe aches
• Diarrhea
• A purple or dark purple rash

Meningococcal disease is not highly contagious. Transmission typically requires close and prolonged contact with saliva, such as through:

• Kissing
• Shared living spaces
• Other direct interactions

It is less contagious than common illnesses like the flu or common cold. Cases are often more prevalent in winter months and are commonly observed among the elderly, teenagers, and young adults.

Public Health Recommendations and Expert Insights

Individuals experiencing any of the listed symptoms are strongly advised to seek immediate medical attention.

The State of Illinois recommends meningococcal ACWY vaccination for all children at ages 11 or 12, with a booster dose recommended at age 16.

Dr. Marielle Fricchione, a pediatric infectious disease physician at RUSH and chair of the Illinois Immunization Advisory Committee, described the cluster of cases with two deaths as "concerning."

Dr. David Nguyen, an infectious disease doctor at Rush University System for Health, highlighted a national rise in cases, suggesting a potential link to lower vaccination rates. He urged the public to ensure their vaccinations are up-to-date, especially if they are in close-quartered or congregate settings.

Recent modifications by the federal Centers for Disease Control and Prevention (CDC) have narrowed broad recommendations for meningococcal disease vaccines, limiting them to specific high-risk groups and leaving the decision for others to parents and doctors. This change has drawn criticism from various medical organizations.

The Itasca-based American Academy of Pediatrics' vaccine schedule continues to broadly recommend meningococcal vaccinations. This stance is endorsed by a dozen medical organizations, including the Chicago-based American Medical Association. Dr. Fricchione emphasized that outbreaks like this "highlight the potential risks of discontinuing vaccination for teenagers and college students," which could facilitate disease spread.